Below are highlights from the February 2026 issue of the Board of Pharmacy newsletter. See the newsletter for details and more information.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Department of Health and Human Services (DHHS) announced the state’s first-year award for the Rural Health Transformation Program from CMS totaling $195,743,566.
Work is underway to support implementation, and DHHS will share the next steps as they are finalized. As the state legislature appropriates funding, the state will begin the process of making awards for the initiatives that will serve rural communities. For questions or to join the contact list for updates, email ruralht@utah.gov.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Division of Professional Licensing (DOPL) issued guidance clarifying the use of the 2025-2026 COVID-19 vaccine following the recommendations from the Advisory Committee on Immunization Practices (ACIP).
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Board of Pharmacy published its August 2025 newsletter including the following items of interest: New Online Toolkit Supports Utah Pharmacists in Managing CS [Controlled Substances] and 2025 Utah Pharmacy Law Update: Therapeutic Interchange and Expanded Pharmacist Authority.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
HB 519, legislation addressing the 340B drug discount program, passed the House and was introduced in the Senate. This bill would prohibit a pharmaceutical manufacturer from restricting, prohibiting or otherwise interfering with a 340B entity's ability to acquire a 340B drug or participate in the 340B drug discount program.
Also in Utah, HB 257, legislation related to health insurance pharmacy benefits, passed the House and was introduced in the Senate. This bill would require a health benefit plan to ensure pharmaceutical rebates are used for certain purposes to benefit enrollees and require a PBM offers certain options to self-funded health benefit plans that (1) comply with provisions of Subsections 31A-22-643(4) and (5), collectively and individually; and (2) do not include spread pricing.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Board of Pharmacy published its February 2025 newsletter, including a reminder of the importance of required self-audits during inspections by the Division of Professional Licensing (DOPL) and an update on compounding operating standards
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Board of Pharmacy posted its May 2024 newsletter.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
On March 13, Gov. Spencer Cox (R) signed SB 207, legislation that prohibits the use of extrapolation in pharmacy audits among various other provisions to update the Pharmacy Practice Act.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Effective February 25, 2024, the Department of Health and Human Services adopted a rule implementing immunization requirements of Title 53G, Chapter 9. Part 3 Immunization Requirements. It establishes minimum immunization requirements for attendance at a public, private, elementary, or secondary school through grade 12, nursery school or kindergarten, licensed day care center, childcare facility, family home care or Head Start program in this state. Of note, pharmacists are among the licensed health care providers who may verify the administration of vaccines on any immunization record. (Utah State Bulletin 2024-03-01, p.92)
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
